HIGHLIGHTS
- who: Po-Wei Chen and collaborators from the Division of Cardiology, Department of Internal Medicine, National Kung University Hospital, College of Medicine, National Kung University, Tainan, Taiwan have published the article: Diverse Effects of Cilostazol on Proprotein Convertase Subtilisin/Kexin Type 9 between Obesity and Non-Obesity, in the Journal: (JOURNAL) of 21/Oct/2015
- what: The authors demonstrated that cilostazol treatment can enhance adiponectin expression in hepatocytes and that the adiponectin/adipoR/AMPK axis plays an important role in cilostazol-induced PCSK9 expression under normal conditions. The study has revealed other mechanisms of action . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.